Z-1349-2020 Class II Terminated
FDA device recall Z-1349-2020 was initiated by Randox Laboratories, Limited on Dec 19, 2019 and is designated Class II. Reason for recall: Software version UI2550642107 for the RX Daytona + instrument released to correct the following issues: 1) The order of samples displayed is not sequential according to SID (sample identification… The recall status is terminated (terminated Apr 23, 2021). Affected quantity: U.S.: RX4040-2 units RX 4041-3 units.
Recall details
- Product Type
- Devices
- Report Date
- Mar 4, 2020
- Initiation Date
- Dec 19, 2019
- Termination Date
- Apr 23, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- U.S.: RX4040-2 units RX 4041-3 units
Product description
RX Daytona Plus (with ISE/without ISE); Models Nos. RX4040 (w/ISE) and RX4041 (without ISE) - Product Usage: A fully automated, random access, clinical chemistry analyzer complete with dedicated analyzer software. For use in clinical laboratories.
Reason for recall
Software version UI2550642107 for the RX Daytona + instrument released to correct the following issues: 1) The order of samples displayed is not sequential according to SID (sample identification number) when searching the run/results screen; 2) Incorrect color flagging of IQC as "out of range."
Distribution pattern
US Nationwide distribution including state of PR.
Code information
Software version UI2550642107 for the RX Daytona Plus instrument.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1349-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026